Search research articles
Contact Us
Filters
Showing results (61-70 of 162) with videos related to
Page
of 17
Sort By:
Human Molecular Genetics
|
November 1, 1993
DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
H L Davis, M L Michel, R G Whalen
Archives of Internal Medicine
|
March 1, 1983
Interaction of rifampin and digitoxin
D M Poor, T H Self, H L Davis
Vaccine
|
March 21, 2001
The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants
M J McCluskie, R D Weeratna, H L Davis
Frontiers of Gastrointestinal Research
|
January 1, 1979
Current adjuvant trials in colorectal cancer
D L Kisner, H L Davis, F M Muggia
The American Journal of Clinical Nutrition
|
September 1, 1971
Evaluating work performance
H L Davis, T W Faulkner, C I Miller
Cancer Research
|
July 15, 1988
Effects of tumor cell viability and inoculum density on growth parameters in the human tumor, soft-agar clonogenic assay
R H Page, E J Tilchen, H L Davis
Federation Proceedings
|
September 1, 1979
Pharmacological and biochemical studies in epileptic fowl
D D Johnson, H L Davis, R D Crawford
Southern Medical Journal
|
November 1, 1978
Characteristics of hospitalized tuberculous patients today
H L Davis, W G White, W D Sutliff
Cancer Treatment Reports
|
September 1, 1981
Phase I trial of PCNU administered by 5-day courses
R H Earhart, J M Koeller, H L Davis
Springer Seminars in Immunopathology
|
August 17, 2000
The role of CpG in DNA vaccines
M J McCluskie, R D Weeratna, H L Davis
Page
of 17
Search research articles
Search
Showing results (61-70 of 162) with videos related to
Sort By:
Page
of 17
Human Molecular Genetics
|
November 1, 1993
DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
H L Davis, M L Michel, R G Whalen
Archives of Internal Medicine
|
March 1, 1983
Interaction of rifampin and digitoxin
D M Poor, T H Self, H L Davis
Vaccine
|
March 21, 2001
The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants
M J McCluskie, R D Weeratna, H L Davis
Frontiers of Gastrointestinal Research
|
January 1, 1979
Current adjuvant trials in colorectal cancer
D L Kisner, H L Davis, F M Muggia
The American Journal of Clinical Nutrition
|
September 1, 1971
Evaluating work performance
H L Davis, T W Faulkner, C I Miller
Cancer Research
|
July 15, 1988
Effects of tumor cell viability and inoculum density on growth parameters in the human tumor, soft-agar clonogenic assay
R H Page, E J Tilchen, H L Davis
Federation Proceedings
|
September 1, 1979
Pharmacological and biochemical studies in epileptic fowl
D D Johnson, H L Davis, R D Crawford
Southern Medical Journal
|
November 1, 1978
Characteristics of hospitalized tuberculous patients today
H L Davis, W G White, W D Sutliff
Cancer Treatment Reports
|
September 1, 1981
Phase I trial of PCNU administered by 5-day courses
R H Earhart, J M Koeller, H L Davis
Springer Seminars in Immunopathology
|
August 17, 2000
The role of CpG in DNA vaccines
M J McCluskie, R D Weeratna, H L Davis
Page
of 17